ZOMDF (Zomedica) Tariff Resilience Score: 6/10 (As of Jun. 30, 2026)


ZOMDF Zomedica Corp ZOMDF
33 GF Score
Price $0.10
GF Value $0.19
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zomedica Tariff Resilience Score?

Zomedica ZOMDF +5.58% 33 Tariff Resilience Score is 6 as of Jun. 30, 2026. GuruFocus rates ZOMDF with a GF Score™ of 33/100 and a GF Value™ of $0.19 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Zomedica ranks better than 91.05% on this metric.

Zomedica has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Zomedica has Zomedica's exposure to tariffs is moderate, with some reliance on imported components. The veterinary industry has niche exemptions, and the company can adjust pricing to mitigate impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Zomedica might have Average Resilient.

Zomedica  (OTCPK:ZOMDF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Zomedica Tariff Resilience Score Related Terms

ZOMDF vs STIM, OM, RPID: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Zomedica's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zomedica Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zomedica's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Zomedica's Tariff Resilience Score falls into.


ZOMDF
33GF Score
Zomedica Corp ZOMDF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Zomedica (ZOMDF) has a Tariff Resilience Score of 6 as of Jun. 30, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Zomedica ranks #75 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 8.9%.
Is Zomedica's Tariff Resilience Score too high?
Zomedica's current Tariff Resilience Score is 6. Based on the distribution chart, Zomedica ranks #75 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zomedica has a GF Score™ of 33/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zomedica's Tariff Resilience Score compare to STIM and OM?
According to the Medical Devices & Instruments industry distribution chart, Zomedica ranks #75 out of 838 companies for Tariff Resilience Score. This places Zomedica in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Zomedica's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zomedica stock overvalued right now?
Based on GuruFocus' analysis, Zomedica (ZOMDF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.19, compared to a current price of $0.10 — trading 46.8% below its estimated fair value. The current Tariff Resilience Score is 6. Zomedica's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Zomedica (ZOMDF), the current Tariff Resilience Score is 6 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zomedica (ZOMDF) Overvalued in 2026?

Based on GuruFocus' analysis, Zomedica stock appears to be undervalued. The current stock price of $0.10 is trading 46.8% below its estimated GF Value™ of $0.19. GuruFocus considers Zomedica to be Significantly Undervalued.

Key valuation signals for ZOMDF:

  • Tariff Resilience Score: 6
  • GF Value™: $0.19 vs. price of $0.10 (46.8% below fair value)
  • GF Score™: 33/100 with 3 warning signs

No single metric tells the full story. See the ZOMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zomedica Business Description

Address 1101 Technology Drive, Suite 100, Ann Arbor, MI, USA, 48108
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its segments consist of Diagnostics, Therapeutic Devices, and Development Services. It earns the majority of revenue from the therapeutics segment, which consists of Assisi, PulseVet, and VETIGEL products.
33GF Score

Get the complete analysis for ZOMDF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price
$0.19
GF Value